Delivery Order SPE2DB20D1100-SPE2DB25FE1LQ
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Kerendia 20 mg tablets (30-count packaging) with a ceiling value of $3,054.85. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The award is processed as a child contract, indicating it derives from a larger indefinite delivery vehicle. The place of performance is listed as the contractor's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,524.88 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,127.32 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 29, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.52 for Kerendia 10 mg tablets (90-count packaging) on July 15, 2025, with an ultimate completion date of July 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $17,656.81 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,335.49 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Kerendia 10 mg tablets (30-count) with a ceiling value of $7,855.53. This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging) valued at $6,857.16. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp received a $1,221.90 firm fixed price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Kerendia 20 mg tablets in a 30-count package. This is a non-set-aside award issued under competitive procurement. The contract is classified as a child order, indicating it derives from a larger indefinite delivery contract vehicle. Performance will be completed by September 18, 2025, with fulfillment occurring at the contractor's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1LQDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, for the supply of Kerendia 10 mg tablets (30-count units) with a ceiling value of $1,212.13. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 30, 2025. The award is being performed from the contractor's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current award for Kerendia, a prescription medication used in diabetes and chronic kidney disease treatment, reflects the company's ongoing role as a critical vendor within the federal pharmaceutical supply chain serving defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/29/25 |